Physician profile
Kelsey E Smith
NPI 1386172922
$2,073.00
in general payments reported to CMS, 2019-2025
15 companies · $676 in 2025
The $676 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $226 · 2023: $311 · 2024: $468 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $801.18 | 2021-2025 | |
| Biogen, INC. | $181.71 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $133.94 | 2021-2025 | Slynd |
| Pfizer INC. | $129.44 | 2023-2025 | |
| Organon LLC | $122.14 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $102.74 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $96.41 | 2022-2025 | |
| Agile Therapeutics, INC. | $92.41 | 2021 | |
| Exact Sciences Corporation | $86.07 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $76.81 | 2021-2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $61.19 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $49.87 | 2021-2023 | Balcoltra |
| Seqirus USA INC | $48.33 | 2024-2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $46.74 | 2024 | Gardasil, Gardasil 9, Vaqta |
| Gynesonics, INC. | $44.02 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.